Structural requirements for functional interaction of glutathione tripeptide analogs with the human multidrug resistance protein 1 (MRP1)

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 643-653

  Leslie, Elaine M ^a   Bowers, Raymond J ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ANION; APIGENIN; ASPARTIC ACID; CYSTINE; ESTRONE SULFATE; GLUCOSE; GLUCURONIC ACID; GLUTATHIONE; GLYCINE; LEUCINE; MULTIDRUG RESISTANCE PROTEIN 1; PHENYLALANINE; SULFATE; TRIPEPTIDE;

ARTICLE; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SUBSTITUTION REACTION;

GLUTATHIONE; HELA CELLS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 20244371290     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044073     Document Type: Article

References (41)

1. Adang AEP, Brussee J, Meyer DJ, Coles B, Ketterer B, van der Gen A, and Mulder GJ (1988) Substrate specificity of rat liver glutathione S-transferase enzymes for a series of glutathione analogues, modified at the γ-glutamyl moiety. Biochem J 255:721-724.
2. Adang AEP, Brussee J, van der Gen A, and Mulder GJ (1990) The glutathione-binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and γ-glutamyl domains. Biochem J 269:47-54.
3. Borst P, Evers R, Kool M, and Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92:1295-1302.
4. Chen Z, Furukawa T, Sumizawa T, Ono K, Ueda K, Seto K, and Akiyama S (1999) ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol Pharmacol 55:921-928.
5. Ciaccio PJ, Shen H, Kruh GD, and Tew KD (1996) Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells. Biochem Biophys Res Commun 222:111-115.
6. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash DC) 258:1650-1654.
7. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910.
8. Conrad S, Kauffmann H.-M., Ito K, Leslie EM, Deeley RG, Schrenk D, and Cole SPC (2002) A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 12:321-330.
9. Dirr H, Reinemer P, and Huber R (1994) X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem 220:645-661.
10. Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, and Borst P (2000) Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 83:375-383.
11. Gallivan JP and Dougherty DA (1999) Cation-π interactions in structural biology. Proc Natl Acad Sci USA 96:9549-9564.
12. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357-361.
13. Gustafsson A, Pettersson PL, Grehn L, Jemth P, and Mannervik B (2001) Role of the glutamyl alpha-carboxylate of the substrate glutathione in the catalytic mechanism of human glutathione transferase A1-1. Biochemistry 40:15835-15845.
14. Hammond CL, Lee TK, and Ballatori N (2001) Novel roles for glutathione in gene expression, cell death and membrane transport of organic solutes. J Hepatol 34:946-954.
15. Heijn M, Hooijberg JH, Scheffer GL, Szabo G, Westerhoff HV, and Lankelma J (1997) Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta 1326:12-22.
16. Hipfner DR, Almquist KC, Stride BD, Deeley RG, and Cole SPC (1996) Location of a protease-hypersensitive region in the Multidrug Resistance Protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res 56:3307-3314.
17. Hipfner DR, Deeley RG, and Cole SPC (1999) Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1461:359-276.
18. Hooijberg JH, Broxterman HJ, Kool M, Assaraf YG, Peters GJ, Scheper RJ, Borst P, Pinedo HM, and Jansen G (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59:2532-2535.
19. Ito K, Olsen SL, Qiu W, Deeley RG, and Cole SPC (2001) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem 276:15616-15624.
20. 4 and structurally related conjugates. J Biol Chem 269:27807-27810.
21. Leslie EM, Deeley RG, and Cole SPC (2001a) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167:3-23.
22. Leslie EM, Deeley RG, and Cole SPC (2003) Bioflavonoid stimulation of glutathione transport by the 190 kDa multidrug resistance protein 1 (MRP1). Drug Metabol Dispos 31:11-15.
23. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, and Cole SPC (2001b) Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1): requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 276:27846-27854.
24. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, and Cole SPC (2001c) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 59:1171-1180.
25. Loe DW, Almquist KC, Deeley RG, and Cole SPC (1996) Multidrug resistance protein (MRP)-mediated transport of leukotriene C 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J Biol Chem 271:9675-9682.
26. Loe DW, Deeley RG, and Cole SPC (1998) Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: evidence for co-transport with reduced glutathione. Cancer Res 58:5130-5136.
27. Loe DW, Deeley RG, and Cole SPC (2000) Verapamil stimulates glutathione transport by the multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 293:530-538.
28. 1 and its glutathione conjugates by the product of the MRP gene. Mol Pharmacol 51:1034-1041.
29. Lucente G, Luisi G, and Pinnen F (1998) Design and synthesis of glutathione analogues. Il Farmaco 53:721-735.
30. 125I]-LY475776: evidence of a major binding site in the COOH-proximal membrane spanning domain. J Biol Chem 277:28690-28699.
31. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, and Oude Elferink RPJ (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338:393-401.
32. 35S]glutathione. J Biol Chem 277:35225-35231.
33. Qian YM, Song WC, Cui H.-R, Cole SPC, and Deeley RG (2001) Glutathione stimulate sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem 276:6404-6411.
34. Rappa G, Lorico A, Flavell RA, and Sartorelli AC (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57:5232-5237.
35. Ren XQ, Furukawa T, Aoki S, Nakajima T, Sumizawa T, Haraguchi M, Chen Z, Kobayashi M, and Akiyama S (2001) Glutathione-dependent binding of a photoaffinity analog of agosterol A to the C-terminal half of human multidrug resistance protein. J Biol Chem 276:23197-23206.
36. Renes J, de Vries EGE, Hooiveld GJEJ, Krikken I, Jansen PLM, and Muller M (2000) Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem J 350:555-561.
37. Sakamoto H, Hara H, Hirano K, and Adachi T (1999) Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated proteinoverexpressing cells. Cancer Lett 135:113-119.
38. Seddon AP and Douglas KT (1980) A photoaffinity label derivative of glutathione and its inhibition of glyoxalase I. FEBS Lett 110:262-264.
39. Versantvoort CHM, Broxterman HJ, Bagrij T, Scheper RJ, and Twentyman PR (1995) Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72:82-89.
40. Whalen R, Kempner ES, and Boyer TD (1996) Structural studies of a human π class glutathione S-transferase. Photoaffinity labeling of the active site and target size analysis. Biochem Pharmacol 52:281-288.
41. Zaman GJR, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F, and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694.